Neurodivergence — particularly ADHD — is increasingly visible across investment and founder led environments. When understood and supported, these traits can be leadership strengths. For investors, recognising how neurodivergence influences decision making, energy and risk is becoming an important value creation lens.
Neurodiversity is now systemic
Female hormonal transitions matter
Hormonal life stages such as pregnancy, postpartum and perimenopause have material impacts on cognitive load and mental health, often coinciding with senior leadership progression. These are predictable, systemic factors — not individual failings — and failure to address them presents a clear retention and performance risk.
Targeted coaching delivers high impact
Well timed coaching, particularly around maternity and other transition points, was highlighted as a highly effective, low-cost intervention. Tailored support can prevent burnout, retain experienced leaders and unlock performance at critical moments.
AI is already shaping practice and policy
AI is being used across clinical, coaching and organisational contexts — from transcription and insight generation to policy design. Subtle shifts, such as more inclusive policy language, demonstrate how technology can meaningfully influence culture and risk management.
Strong investment themes despite short term friction
FemTech and digital mental health remain compelling investment areas, supported by increasing clinical rigour and scalability. While regulatory uncertainty — particularly around private ADHD diagnosis — is causing temporary friction, this was widely viewed as a pause rather than a structural shift.
Reframing the ADHD Narrative
The panel challenged claims of ADHD overdiagnosis, particularly in women. Clinicians emphasised historical under recognition and misattribution, compounded by NHS backlogs and variable quality in private provision.
Key takeaways
Thank you to our excellent panellists for the expertise and insights and making this a meaningful discussion.
Kate Organ, MRPharms, Msc
British Menopause Society (BMS) Registered Menopause Specialist
Consultant Pharmacist Menopause and PMS Specialist
https://www.menopausespecialists.com/
https://www.linkedin.com/in/kate-organ-412b07a2/
email: Kate@menopausespecialists.com
Catherine Lightfoot
Executive ADHD Coach, People & Culture Consultant
https://fireandlightcoaching.com/
https://www.linkedin.com/in/catherine-lightfoot-coach/
email: catherine@fireandlightcoaching.com
Anne-Marie Heelis
Associate Director | Healthcare & Life Sciences Deal Origination EMA
KPMG LLP
M: +44 (0) 7785 477 677
Email: anne-marie.heelis@kpmg.co.uk
https://www.linkedin.com/in/anne-marie-heelis/
Our value creation insights
Something went wrong
Oops!! Something went wrong, please try again
Get in touch
Discover why organisations across the UK trust KPMG to make the difference and how we can help you to do the same.